Product: EXPAREL (bupivacaine liposome injectable suspension),  1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA
Reason for recall: Subpotent; bupivacaine
Recall initiated: 20121217
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated